Covance Inc. (CVD) - Strategic SWOT Analysis Review
- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – GlobalData’s summarization of the company’s business strategy.
SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Key manufacturing facilities – A list of key manufacturing facilities of the company.
Covance Inc. (Covance) is a drug development company that offers contract research services. The company offers a broad range of early-stage and late-stage product development services to pharmaceutical, biotechnology and medical device companies. It also offers services including laboratory testing for agrochemical, chemical and food industries. The early-stage development services that the company offers include preclinical and clinical pharmacology services and discovery support services. Its late-stage development services include Phase II-IV clinical development, central laboratory and market access services. The company operates across the US, Europe, South America and Asia-Pacific. Covance is a subsidiary of LabCorp and is headquartered in Princeton, New Jersey, the US.
Covance Inc. Key Recent Developments
Feb 04, 2015: Covance Reports Fourth Quarter Net Revenue Of $634 Million, Pro Forma EPS Of $0.97 And Record Adjusted Net Orders Of $823 Million Jan 20, 2015: Covance Launches New Solution to Bridge Preclinical to Clinical Development Nov 18, 2013: Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials Nov 11, 2013: Covance To Present At The Credit Suisse Healthcare Conference Oct 29, 2013: Covance Reports Third Quarter Net Revenue Of $607 Million, Pro Forma EPS Of $0.83 And Adjusted Net Orders Of $732 Million
Reasons to Buy
Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.